Analyst Ratings for Stemline Therapeutics (STML) [Buys]

STML Rating Summary

  |   Expand Research on STML
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 6 / 10   Percentile Rank: 61%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
12/24/2019 Cantor Fitzgerald
» Updated 3/27/2020
Alethia Young New Coverage Overweight
(N/A)
10.00
(18.00)
10.49
(11.83)
12.77% Details
5/24/2019 Roth Capital Jerry Issacson New Coverage Buy
(N/A)
33.00
(N/A)
15.13
(11.83)
-21.81% Details
Like STML Ratings? Also take a look at

STML Ratings News